Endo Pharma (ENDP) Reports In-Line Q1 EPS; Reaffirms Outlook
Tweet Send to a Friend
Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP) reported Q1 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
